Results 101 to 110 of about 54,264 (302)
Mycoplasma hominis impacts gene expression in Trichomonas vaginalis
Parasitology Research, 2018 In Europe, up to 90% of isolated Trichomonas vaginalis strains are naturally infected with Mycoplasma hominis, a facultative pathogen of the human genital tract. The consequences of this endosymbiosis are not yet well understood.
U. Fürnkranz, B. Henrich, J. Walochnik
semanticscholar +1 more source
Academic Emergency Medicine, Volume 32, Issue 8, Page 941-946, August 2025.
David A. Talan +2 more
wiley +1 more source
Ecology and Evolution, Volume 15, Issue 5, May 2025.This study investigated the prevalence and diversity of Matryoshka RNA viruses (MaRNAV) in wild birds in the San Francisco Bay Area, California. Using RNA sequencing and RT‐PCR, we identified two novel MaRNAVs (MaRNAV‐5 and ‐6) associated with haemosporidian infections in passerines and raptors. These findings suggest a high prevalence of these viruses,
Carlos W. Esperanza +3 more
wiley +1 more source
Suboptimal \u3cem\u3eTrichomonas vaginalis\u3c/em\u3e Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community [PDF]
, 2016 Trichomonas vaginalis is the most common nonviral etiology of sexually transmitted infection (STI) worldwide. The OSOM Trichomonas rapid test (OSOM; Sekisui Diagnostics, San Diego, CA) is a rapid surrogate to microscopic analysis in symptomatic patients,
Munson, Erik +2 more
core +1 more source
Association between Trichomonas vaginalis and prostate cancer mortality
International Journal of Cancer, 2018 We previously observed a positive association between seropositivity for the parasite Trichomonas vaginalis and risk of clinically significant prostate cancer at diagnosis. Here, we examined whether T.
Sabrina H. Tsang +8 more
semanticscholar +1 more source
Journal of the International AIDS Society, Volume 28, Issue 5, May 2025.Abstract Introduction Pre‐exposure prophylaxis (PrEP) services are linked to increased sexually transmitted infection (STI) diagnoses, which may facilitate PrEP uptake. We hypothesized that point‐of‐care (POC) STI testing and treatment would improve PrEP initiation and persistence. Methods Between September 2023 and November 2024, we conducted a single‐
Dvora Joseph Davey +8 more
wiley +1 more source
Development of a SimpleProbe real-Time PCR Assay for rapid detection and identification of the US novel urethrotropic clade of Neisseria meningitidis ST-11 (US_NmUC) [PDF]
, 2020 Urethritis, or inflammation of the urethra, is one of the most common reasons men seek clinical care. Sexually transmitted pathogens including Neisseria gonorrhoeae are responsible for over half of the symptomatic urethritis cases in U.S. men.
Ermel, Aaron +4 more
core +1 more source
Trichomonas vaginalis Pharmacological Treatment
, 2021 Trichomoniasis is the most common sexually transmitted protozoan infection, which has been treated for several decades using nitroimidazoles, mainly metronidazole and tinidazole. Both drugs are still recommended and resistance to them has fortunately been a relatively rare phenomenon.
openaire +5 more sources
Microbial Biotechnology, Volume 18, Issue 5, May 2025.LAMP assay for point‐of‐care tests. ABSTRACT Sexually transmitted infections (STIs) remain a significant public health concern. Given the asymptomatic nature of many STIs, diagnostic testing is critical for determining the appropriate treatment, enabling effective tracing and reducing the risk of further transmission.
Yasaman Ahmadi +4 more
wiley +1 more source
Expansion of Comprehensive Screening of Male Sexually Transmitted Infection Clinic Attendees with \u3cem\u3eMycoplasma genitalium\u3c/em\u3e and \u3cem\u3eTrichomonas vaginalis\u3c/em\u3e Molecular Assessment: a Retrospective Analysis [PDF]
, 2017 Of 1,493 encounters of males at a sexually transmitted infection (STI) clinic in a community with a high prevalence of STI, Chlamydia trachomatis was detected in 8.7% and Neisseria gonorrhoeae was detected in 6.6%.
Gerritts, Joshua +9 more
core +1 more source